Posts

Showing posts with the label Pulmonary Alveolar Proteinosis (PAP)

Translate

Outlook (2017-2025) on Global Pulmonary Alveolar Proteinosis (PAP) Market: Industry Analysis : Pharmaceutical

Press Release - 09 April 2018 Global Research and Development News -- . . Report Description- ' ' Pulmonary alveolar proteinosis (PAP) is a rare respiratory disease caused by the accumulation of a surfactant (proteins and lipids) accumulated in small air bags of the lung, called alveoli, which interfere with breathing. PAP condition occurs in 6 individuals per million and is considered an orphan disease. Pulmonary surfactant is produced by the body in healthy people and patients with PAP, which is a mixture of phospholipids and synthesized proteins. These surfactants form cell lines to prevent the collapse of the pulmonary membranes by reducing the surface tension. This pulmonary surfactant must be constantly replaced to maintain the active and functional layer and to prevent excessive layering. The exact reason for the accumulation of excess surfactants is unknown. This requires a s